We are analyzing https://link.springer.com/article/10.1186/s13046-024-03132-6.

Title:
tsRNA-GlyGCC promotes colorectal cancer progression and 5-FU resistance by regulating SPIB | Journal of Experimental & Clinical Cancer Research
Description:
Background tRNA-derived small RNAs (tsRNAs) are newly discovered non-coding RNA, which are generated from tRNAs and are reported to participate in several biological processes in diseases, especially cancer; however, the mechanism of tsRNA involvement in colorectal cancer (CRC) and 5-fluorouracil (5-FU) is still unclear. Methods RNA sequencing was performed to identify differential expression of tsRNAs in CRC tissues. CCK8, colony formation, transwell assays, and tumor sphere assays were used to investigate the role of tsRNA-GlyGCC in 5-FU resistance in CRC. TargetScan and miRanda were used to identify the target genes of tsRNA-GlyGCC. Biotin pull-down, RNA pull-down, luciferase assay, ChIP, and western blotting were used to explore the underlying molecular mechanisms of action of tsRNA-GlyGCC. The MeRIP assay was used to investigate the N(7)-methylguanosine RNA modification of tsRNA-GlyGCC. Results In this study, we uncovered the feature of tsRNAs in human CRC tissues and confirmed a specific 5’ half tRNA, 5’tiRNA-Gly-GCC (tsRNA-GlyGCC), which is upregulated in CRC tissues and modulated by METTL1-mediated N(7)-methylguanosine tRNA modification. In vitro and in vivo experiments revealed the oncogenic role of tsRNA-GlyGCC in 5-FU drug resistance in CRC. Remarkably, our results showed that tsRNA-GlyGCC modulated the JAK1/STAT6 signaling pathway by targeting SPIB. Poly (β-amino esters) were synthesized to assist the delivery of 5-FU and tsRNA-GlyGCC inhibitor, which effectively inhibited tumor growth and enhanced CRC sensitive to 5-FU without obvious adverse effects in subcutaneous tumor. Conclusions Our study revealed a specific tsRNA-GlyGCC-engaged pathway in CRC progression. Targeting tsRNA-GlyGCC in combination with 5-FU may provide a promising nanotherapeutic strategy for the treatment of 5-FU-resistance CRC. Graphical Abstract
Website Age:
28 years and 1 months (reg. 1997-05-29).

Matching Content Categories {📚}

Science
Education
Health & Fitness

Content Management System {📝}

What CMS is link.springer.com built with?

Custom-built

No common CMS systems were detected on Link.springer.com, and no known web development framework was identified.

Traffic Estimate {📈}

What is the average monthly size of link.springer.com audience?

🌠 Phenomenal Traffic: 5M - 10M visitors per month

Based on our best estimate, this website will receive around 5,000,019 visitors per month in the current month.
However, some sources were not loaded, we suggest to reload the page to get complete results.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Link.springer.com Make Money? {💸}

We can't tell how the site generates income.

Not all websites focus on profit; some are designed to educate, connect people, or share useful tools. People create websites for numerous reasons. And this could be one such example. Link.springer.com might be making money, but it's not detectable how they're doing it.

Keywords {🔍}

tsrnaglygcc, crc, cancer, pubmed, spib, article, cells, fig, expression, resistance, google, scholar, cas, tissues, cell, figure, inhibitor, paefutsinhibitor, tumor, tsrna, groups, trna, zhang, rna, assay, significantly, showed, colorectal, central, stat, results, wang, tsrnas, mice, chen, data, role, mettl, liu, study, drug, analysis, modification, jakstat, pathway, promotes, size, treated, protein, detect,

Topics {✒️}

cn/server/irna-m7g/predictor hypoxia-induced trna-derived fragments specific tsrna-glygcc-engaged pathway anti-rabbit igg antibody tsrna-glygcc inhibitor-loaded nanocarriers cn/server/irna-m7g/ triple-negative breast cancer article download pdf rptor/ulk1/autophagy axis trastuzumab-resistant breast cancer tsrna-glygcc inhibitor reduced stem-loop rt-pcr high-throughput genomic research annexin v-fitc jak/stat signaling pathway wilcoxon-mann-whitney test free tsrna inhibitor-cy5 central south university jak1/stat6 signaling pathway trna-derived small rna anti-mouse igg antibody trna-derived fragment biogenesis tsrna-glygcc specific inhibitor tsrna-glygcc inhibitor decreased loading tsrna-glygcc inhibitor tsrna-glygcc antagomir decreased means ± sd pi3k-akt signaling pathways 5’trna-gly-gcc m7g mettl1-silenced cells compared spi-b-mediated silencing tsrna-glygcc agomir/antagomir full access nc antagomir/tsrna antagomir a-rna methylation recognized tsrna-glygcc inhibitor groups tsrna-glygcc-targeting inhibitors drug-resistant cancer therapy pae-inhibitor complex trna-derived small high tsrna-glygcc expression binding-fragment enrichment analyses 5-fu + tsrna antagomir groups /shrna complex nanoparticles regulate protein-coding genes mettl1 promotes tumorigenesis promote cancer stemness circmdk promotes tumorigenesis anti-7-methylguanosine antibody privacy choices/manage cookies

Schema {🗺️}

WebPage:
      mainEntity:
         headline:tsRNA-GlyGCC promotes colorectal cancer progression and 5-FU resistance by regulating SPIB
         description:tRNA-derived small RNAs (tsRNAs) are newly discovered non-coding RNA, which are generated from tRNAs and are reported to participate in several biological processes in diseases, especially cancer; however, the mechanism of tsRNA involvement in colorectal cancer (CRC) and 5-fluorouracil (5-FU) is still unclear. RNA sequencing was performed to identify differential expression of tsRNAs in CRC tissues. CCK8, colony formation, transwell assays, and tumor sphere assays were used to investigate the role of tsRNA-GlyGCC in 5-FU resistance in CRC. TargetScan and miRanda were used to identify the target genes of tsRNA-GlyGCC. Biotin pull-down, RNA pull-down, luciferase assay, ChIP, and western blotting were used to explore the underlying molecular mechanisms of action of tsRNA-GlyGCC. The MeRIP assay was used to investigate the N(7)-methylguanosine RNA modification of tsRNA-GlyGCC. In this study, we uncovered the feature of tsRNAs in human CRC tissues and confirmed a specific 5’ half tRNA, 5’tiRNA-Gly-GCC (tsRNA-GlyGCC), which is upregulated in CRC tissues and modulated by METTL1-mediated N(7)-methylguanosine tRNA modification. In vitro and in vivo experiments revealed the oncogenic role of tsRNA-GlyGCC in 5-FU drug resistance in CRC. Remarkably, our results showed that tsRNA-GlyGCC modulated the JAK1/STAT6 signaling pathway by targeting SPIB. Poly (β-amino esters) were synthesized to assist the delivery of 5-FU and tsRNA-GlyGCC inhibitor, which effectively inhibited tumor growth and enhanced CRC sensitive to 5-FU without obvious adverse effects in subcutaneous tumor. Our study revealed a specific tsRNA-GlyGCC-engaged pathway in CRC progression. Targeting tsRNA-GlyGCC in combination with 5-FU may provide a promising nanotherapeutic strategy for the treatment of 5-FU-resistance CRC.
         datePublished:2024-08-17T00:00:00Z
         dateModified:2024-08-17T00:00:00Z
         pageStart:1
         pageEnd:17
         license:http://creativecommons.org/publicdomain/zero/1.0/
         sameAs:https://doi.org/10.1186/s13046-024-03132-6
         keywords:
            tsRNA
            5-FU resistance
            CRC
            SPIB
            m7G
            METTL1
            JAK1/STAT6
            Cancer Research
            Immunology
            Apoptosis
            Oncology
         image:
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs13046-024-03132-6/MediaObjects/13046_2024_3132_Figa_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs13046-024-03132-6/MediaObjects/13046_2024_3132_Fig1_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs13046-024-03132-6/MediaObjects/13046_2024_3132_Fig2_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs13046-024-03132-6/MediaObjects/13046_2024_3132_Fig3_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs13046-024-03132-6/MediaObjects/13046_2024_3132_Fig4_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs13046-024-03132-6/MediaObjects/13046_2024_3132_Fig5_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs13046-024-03132-6/MediaObjects/13046_2024_3132_Fig6_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs13046-024-03132-6/MediaObjects/13046_2024_3132_Fig7_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs13046-024-03132-6/MediaObjects/13046_2024_3132_Fig8_HTML.png
         isPartOf:
            name:Journal of Experimental & Clinical Cancer Research
            issn:
               1756-9966
            volumeNumber:43
            type:
               Periodical
               PublicationVolume
         publisher:
            name:BioMed Central
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:Rong Xu
               affiliation:
                     name:Central South University (The first people’s hospital of Changde city)
                     address:
                        name:Department of Pathology, Changde Hospital, Xiangya School of Medicine, Central South University (The first people’s hospital of Changde city), Changde, China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Ashuai Du
               affiliation:
                     name:Guizhou Provincial people’s Hospital
                     address:
                        name:Department of Infectious Diseases, Guizhou Provincial people’s Hospital, Guiyang, China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Xinpei Deng
               affiliation:
                     name:Sun Yat-sen University Cancer Center
                     address:
                        name:State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou, China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Wei Du
               affiliation:
                     name:Central South University (The first people’s hospital of Changde city)
                     address:
                        name:Department of Pathology, Changde Hospital, Xiangya School of Medicine, Central South University (The first people’s hospital of Changde city), Changde, China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Kaiying Zhang
               affiliation:
                     name:Sun Yat-sen University Cancer Center
                     address:
                        name:State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou, China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Jianbo Li
               affiliation:
                     name:Xiangya Changde Hospital
                     address:
                        name:Department of Pathology, Xiangya Changde Hospital, Changde, China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Yingxue Lu
               affiliation:
                     name:Guizhou Provincial people’s Hospital
                     address:
                        name:Department of Infectious Diseases, Guizhou Provincial people’s Hospital, Guiyang, China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Xiaoli Wei
               affiliation:
                     name:Sun Yat-sen University Cancer Center
                     address:
                        name:State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou, China
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
               name:Qinglong Yang
               affiliation:
                     name:Guizhou Provincial people’s Hospital
                     address:
                        name:Department of General Surgery, Guizhou Provincial people’s Hospital, Guiyang, China
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
               name:Hailin Tang
               url:http://orcid.org/0000-0002-3206-782X
               affiliation:
                     name:Sun Yat-sen University Cancer Center
                     address:
                        name:State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou, China
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
         isAccessibleForFree:1
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:tsRNA-GlyGCC promotes colorectal cancer progression and 5-FU resistance by regulating SPIB
      description:tRNA-derived small RNAs (tsRNAs) are newly discovered non-coding RNA, which are generated from tRNAs and are reported to participate in several biological processes in diseases, especially cancer; however, the mechanism of tsRNA involvement in colorectal cancer (CRC) and 5-fluorouracil (5-FU) is still unclear. RNA sequencing was performed to identify differential expression of tsRNAs in CRC tissues. CCK8, colony formation, transwell assays, and tumor sphere assays were used to investigate the role of tsRNA-GlyGCC in 5-FU resistance in CRC. TargetScan and miRanda were used to identify the target genes of tsRNA-GlyGCC. Biotin pull-down, RNA pull-down, luciferase assay, ChIP, and western blotting were used to explore the underlying molecular mechanisms of action of tsRNA-GlyGCC. The MeRIP assay was used to investigate the N(7)-methylguanosine RNA modification of tsRNA-GlyGCC. In this study, we uncovered the feature of tsRNAs in human CRC tissues and confirmed a specific 5’ half tRNA, 5’tiRNA-Gly-GCC (tsRNA-GlyGCC), which is upregulated in CRC tissues and modulated by METTL1-mediated N(7)-methylguanosine tRNA modification. In vitro and in vivo experiments revealed the oncogenic role of tsRNA-GlyGCC in 5-FU drug resistance in CRC. Remarkably, our results showed that tsRNA-GlyGCC modulated the JAK1/STAT6 signaling pathway by targeting SPIB. Poly (β-amino esters) were synthesized to assist the delivery of 5-FU and tsRNA-GlyGCC inhibitor, which effectively inhibited tumor growth and enhanced CRC sensitive to 5-FU without obvious adverse effects in subcutaneous tumor. Our study revealed a specific tsRNA-GlyGCC-engaged pathway in CRC progression. Targeting tsRNA-GlyGCC in combination with 5-FU may provide a promising nanotherapeutic strategy for the treatment of 5-FU-resistance CRC.
      datePublished:2024-08-17T00:00:00Z
      dateModified:2024-08-17T00:00:00Z
      pageStart:1
      pageEnd:17
      license:http://creativecommons.org/publicdomain/zero/1.0/
      sameAs:https://doi.org/10.1186/s13046-024-03132-6
      keywords:
         tsRNA
         5-FU resistance
         CRC
         SPIB
         m7G
         METTL1
         JAK1/STAT6
         Cancer Research
         Immunology
         Apoptosis
         Oncology
      image:
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs13046-024-03132-6/MediaObjects/13046_2024_3132_Figa_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs13046-024-03132-6/MediaObjects/13046_2024_3132_Fig1_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs13046-024-03132-6/MediaObjects/13046_2024_3132_Fig2_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs13046-024-03132-6/MediaObjects/13046_2024_3132_Fig3_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs13046-024-03132-6/MediaObjects/13046_2024_3132_Fig4_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs13046-024-03132-6/MediaObjects/13046_2024_3132_Fig5_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs13046-024-03132-6/MediaObjects/13046_2024_3132_Fig6_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs13046-024-03132-6/MediaObjects/13046_2024_3132_Fig7_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs13046-024-03132-6/MediaObjects/13046_2024_3132_Fig8_HTML.png
      isPartOf:
         name:Journal of Experimental & Clinical Cancer Research
         issn:
            1756-9966
         volumeNumber:43
         type:
            Periodical
            PublicationVolume
      publisher:
         name:BioMed Central
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:Rong Xu
            affiliation:
                  name:Central South University (The first people’s hospital of Changde city)
                  address:
                     name:Department of Pathology, Changde Hospital, Xiangya School of Medicine, Central South University (The first people’s hospital of Changde city), Changde, China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Ashuai Du
            affiliation:
                  name:Guizhou Provincial people’s Hospital
                  address:
                     name:Department of Infectious Diseases, Guizhou Provincial people’s Hospital, Guiyang, China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Xinpei Deng
            affiliation:
                  name:Sun Yat-sen University Cancer Center
                  address:
                     name:State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou, China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Wei Du
            affiliation:
                  name:Central South University (The first people’s hospital of Changde city)
                  address:
                     name:Department of Pathology, Changde Hospital, Xiangya School of Medicine, Central South University (The first people’s hospital of Changde city), Changde, China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Kaiying Zhang
            affiliation:
                  name:Sun Yat-sen University Cancer Center
                  address:
                     name:State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou, China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Jianbo Li
            affiliation:
                  name:Xiangya Changde Hospital
                  address:
                     name:Department of Pathology, Xiangya Changde Hospital, Changde, China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Yingxue Lu
            affiliation:
                  name:Guizhou Provincial people’s Hospital
                  address:
                     name:Department of Infectious Diseases, Guizhou Provincial people’s Hospital, Guiyang, China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Xiaoli Wei
            affiliation:
                  name:Sun Yat-sen University Cancer Center
                  address:
                     name:State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou, China
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
            name:Qinglong Yang
            affiliation:
                  name:Guizhou Provincial people’s Hospital
                  address:
                     name:Department of General Surgery, Guizhou Provincial people’s Hospital, Guiyang, China
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
            name:Hailin Tang
            url:http://orcid.org/0000-0002-3206-782X
            affiliation:
                  name:Sun Yat-sen University Cancer Center
                  address:
                     name:State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou, China
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
      isAccessibleForFree:1
["Periodical","PublicationVolume"]:
      name:Journal of Experimental & Clinical Cancer Research
      issn:
         1756-9966
      volumeNumber:43
Organization:
      name:BioMed Central
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:Central South University (The first people’s hospital of Changde city)
      address:
         name:Department of Pathology, Changde Hospital, Xiangya School of Medicine, Central South University (The first people’s hospital of Changde city), Changde, China
         type:PostalAddress
      name:Guizhou Provincial people’s Hospital
      address:
         name:Department of Infectious Diseases, Guizhou Provincial people’s Hospital, Guiyang, China
         type:PostalAddress
      name:Sun Yat-sen University Cancer Center
      address:
         name:State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou, China
         type:PostalAddress
      name:Central South University (The first people’s hospital of Changde city)
      address:
         name:Department of Pathology, Changde Hospital, Xiangya School of Medicine, Central South University (The first people’s hospital of Changde city), Changde, China
         type:PostalAddress
      name:Sun Yat-sen University Cancer Center
      address:
         name:State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou, China
         type:PostalAddress
      name:Xiangya Changde Hospital
      address:
         name:Department of Pathology, Xiangya Changde Hospital, Changde, China
         type:PostalAddress
      name:Guizhou Provincial people’s Hospital
      address:
         name:Department of Infectious Diseases, Guizhou Provincial people’s Hospital, Guiyang, China
         type:PostalAddress
      name:Sun Yat-sen University Cancer Center
      address:
         name:State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou, China
         type:PostalAddress
      name:Guizhou Provincial people’s Hospital
      address:
         name:Department of General Surgery, Guizhou Provincial people’s Hospital, Guiyang, China
         type:PostalAddress
      name:Sun Yat-sen University Cancer Center
      address:
         name:State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou, China
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:Rong Xu
      affiliation:
            name:Central South University (The first people’s hospital of Changde city)
            address:
               name:Department of Pathology, Changde Hospital, Xiangya School of Medicine, Central South University (The first people’s hospital of Changde city), Changde, China
               type:PostalAddress
            type:Organization
      name:Ashuai Du
      affiliation:
            name:Guizhou Provincial people’s Hospital
            address:
               name:Department of Infectious Diseases, Guizhou Provincial people’s Hospital, Guiyang, China
               type:PostalAddress
            type:Organization
      name:Xinpei Deng
      affiliation:
            name:Sun Yat-sen University Cancer Center
            address:
               name:State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou, China
               type:PostalAddress
            type:Organization
      name:Wei Du
      affiliation:
            name:Central South University (The first people’s hospital of Changde city)
            address:
               name:Department of Pathology, Changde Hospital, Xiangya School of Medicine, Central South University (The first people’s hospital of Changde city), Changde, China
               type:PostalAddress
            type:Organization
      name:Kaiying Zhang
      affiliation:
            name:Sun Yat-sen University Cancer Center
            address:
               name:State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou, China
               type:PostalAddress
            type:Organization
      name:Jianbo Li
      affiliation:
            name:Xiangya Changde Hospital
            address:
               name:Department of Pathology, Xiangya Changde Hospital, Changde, China
               type:PostalAddress
            type:Organization
      name:Yingxue Lu
      affiliation:
            name:Guizhou Provincial people’s Hospital
            address:
               name:Department of Infectious Diseases, Guizhou Provincial people’s Hospital, Guiyang, China
               type:PostalAddress
            type:Organization
      name:Xiaoli Wei
      affiliation:
            name:Sun Yat-sen University Cancer Center
            address:
               name:State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou, China
               type:PostalAddress
            type:Organization
      email:[email protected]
      name:Qinglong Yang
      affiliation:
            name:Guizhou Provincial people’s Hospital
            address:
               name:Department of General Surgery, Guizhou Provincial people’s Hospital, Guiyang, China
               type:PostalAddress
            type:Organization
      email:[email protected]
      name:Hailin Tang
      url:http://orcid.org/0000-0002-3206-782X
      affiliation:
            name:Sun Yat-sen University Cancer Center
            address:
               name:State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou, China
               type:PostalAddress
            type:Organization
      email:[email protected]
PostalAddress:
      name:Department of Pathology, Changde Hospital, Xiangya School of Medicine, Central South University (The first people’s hospital of Changde city), Changde, China
      name:Department of Infectious Diseases, Guizhou Provincial people’s Hospital, Guiyang, China
      name:State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou, China
      name:Department of Pathology, Changde Hospital, Xiangya School of Medicine, Central South University (The first people’s hospital of Changde city), Changde, China
      name:State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou, China
      name:Department of Pathology, Xiangya Changde Hospital, Changde, China
      name:Department of Infectious Diseases, Guizhou Provincial people’s Hospital, Guiyang, China
      name:State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou, China
      name:Department of General Surgery, Guizhou Provincial people’s Hospital, Guiyang, China
      name:State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou, China

Social Networks {👍}(1)

https://link.springer.com/article/10.1186/s13046-024-03132-6/mailto:[email protected]

External Links {🔗}(228)

Analytics and Tracking {📊}

Google Tag Manager

Libraries {📚}

Clipboard.js
Prism.js

5.39s.

LINK . SPRINGER . COM {}